Albert Cha

Insider Reports History

Entity
Individual
Location
505 Hamilton Avenue, Suite 200, Palo Alto, CA
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Albert Cha:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KalVista Pharmaceuticals, Inc. Director Stock Option (right to buy) 10K Sep 26, 2023 Direct

Insider Reports Filed by Albert Cha

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALV KalVista Pharmaceuticals, Inc. Sep 26, 2023 1 $0 4 Sep 28, 2023 Director
KALV KalVista Pharmaceuticals, Inc. Sep 11, 2023 5 -$54.2K 4 Sep 13, 2023 Director
KALV KalVista Pharmaceuticals, Inc. Oct 13, 2022 1 $0 4 Oct 17, 2022 Director
KALV KalVista Pharmaceuticals, Inc. Sep 30, 2021 1 $0 4 Oct 1, 2021 Director